COVID-19 medicines under evaluation
The European Medicines Agency (EMA) is evaluating potential COVID-19 vaccines and treatments to enable promising medicines to reach patients in the European Union (EU) as soon as possible.
HumanCOVID-19
On Monday, 12 January 2026, between 07:00 and 10:00 CET (Amsterdam time), this website will be unavailable due to scheduled maintenance.
There are currently no COVID-19 medicines under evaluation by EMA's Committee for Medicinal Products for Human Use (CHMP).